References
- van Laar MW, van Miltenburg CJA. Epidemiology of hallucinogenic drug use in The Netherlands. Tijdschr Psychiatr. 2020;62(8):684–692.
- Carvalho M, Carmo H, Costa VM, et al. Toxicity of amphetamines: an update. Arch Toxicol. 2012;86(8):1167–1231.
- Kung SW, Chan YC, Tse ML, et al. Accidental ecstasy poisoning in a five-year-old boy. Hong Kong J Emerg Med. 2008;15(2):111–114.
- Montesdeoca Melian A, Burillo-Putze G, Gonzalez Campo C, et al. Accidental ecstasy poisoning in a toddler. Pediatr Emerg Care. 2004;20:534–535.
- Kalant H. The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs. CMAJ. 2001;165(7):917–928.
- Lee T, Warrick BJ, Sarangarm P, et al. Levetiracetam in toxic seizures. Clin Toxicol. 2018;56(3):175–181.
- Fletcher ML, Sarangarm P, Nash J, et al. A systematic review of second line therapies in toxic seizures. Clin Toxicol. 2021;59(6):451–456.